By slowing gastric emptying and altering gut motility, semaglutide can change the guts microbial landscape, potentially allowing yeast to thrive
Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss
In seeking to understand the impact of the use of weight-loss drugs across current and future portfolios as an emerging trend, practical options include asking ceding insurers detailed questions about online prescribing, remote triage, clinical governance, patient followup, warning language, pharmacy verification, storage controls, and counterfeit-risk mitigation
For lean women with PCOS who dont meet weight eligibility criteria, prescribing a GLP-1 specifically for PCOS symptoms is fully off-label